Euscaphic acid isolated from roots of Rosa rugosa inhibits LPS-induced inflammatory responses via TLR4-mediated NF-κB inactivation in RAW 264.7 macrophages

J Cell Biochem. 2012 Jun;113(6):1936-46. doi: 10.1002/jcb.24062.

Abstract

As an attempt to search for bioactive natural products exerting anti-inflammatory activity, we have evaluated the anti-inflammatory effects of euscaphic acid (19α-hydroxyursane-type triterpenoids, EA) isolated from roots of Rosa rugosa and its underlying molecular mechanisms in lipopolysaccharide (LPS)-induced RAW 264.7 macrophages. EA concentration-dependently reduced the production of nitric oxide (NO), prostaglandin E2 (PGE2), tumor necrosis factor-α (TNF-α), and interleukin-1β (IL-1β) induced by LPS in RAW 264.7 macgophages. Consistent with these data, expression levels of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) protein and iNOS, COX-2, TNF-α, and IL-1β mRNA were inhibited by EA in a concentration-dependent manner. In addition, EA attenuated LPS-induced DNA binding and transcriptional activity of nuclear factor-kappa B (NF-κB), which was accompanied by a parallel reduction of degradation and phosphorylation of inhibitory kappa Bα (IκBα) and consequently by decreased nuclear translocation of p65 subunit of NF-κB. Pretreatment with EA significantly inhibited the LPS-induced phosphorylation of IκB kinase β (IKKβ), p38, and JNK, whereas the phosphorylation of ERK1/2 was unaffected. Furthermore, EA interfered with the LPS-induced clustering of TNF receptor-associated factor 6 (TRAF6) with interleukin receptor associated kinase 1 (IRAK1) and transforming growth factor-β-activated kinase 1 (TAK1). Taken together, these results suggest that EA inhibits LPS-induced inflammatory responses by interference with the clustering of TRAF6 with IRAK1 and TAK1, resulting in blocking the activation of IKK and MAPKs signal transduction to downregulate NF-κB activations.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Line
  • Cyclooxygenase 2 / biosynthesis
  • Dinoprostone / biosynthesis
  • Extracellular Signal-Regulated MAP Kinases / metabolism
  • I-kappa B Proteins / metabolism
  • Inflammation / drug therapy*
  • Interleukin-1 Receptor-Associated Kinases / metabolism
  • Interleukin-1beta / biosynthesis
  • JNK Mitogen-Activated Protein Kinases / metabolism
  • Lipopolysaccharides / immunology
  • MAP Kinase Kinase Kinases / metabolism
  • MAP Kinase Signaling System / drug effects
  • Macrophages / drug effects
  • Macrophages / immunology*
  • Macrophages / metabolism
  • Mice
  • NF-KappaB Inhibitor alpha
  • NF-kappa B / metabolism*
  • Nitric Oxide / biosynthesis
  • Nitric Oxide Synthase Type II / biosynthesis
  • Phosphorylation / drug effects
  • Phytotherapy
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Rosa / chemistry
  • TNF Receptor-Associated Factor 6 / drug effects
  • TNF Receptor-Associated Factor 6 / metabolism
  • Toll-Like Receptor 4 / metabolism*
  • Transcription Factor RelA / metabolism
  • Transcription, Genetic / drug effects
  • Triterpenes / pharmacology*
  • Tumor Necrosis Factor-alpha / biosynthesis
  • p38 Mitogen-Activated Protein Kinases / metabolism

Substances

  • I-kappa B Proteins
  • Interleukin-1beta
  • Lipopolysaccharides
  • NF-kappa B
  • Nfkbia protein, mouse
  • RNA, Messenger
  • Rela protein, mouse
  • TNF Receptor-Associated Factor 6
  • Tlr4 protein, mouse
  • Toll-Like Receptor 4
  • Transcription Factor RelA
  • Triterpenes
  • Tumor Necrosis Factor-alpha
  • NF-KappaB Inhibitor alpha
  • Nitric Oxide
  • euscaphic acid
  • Nitric Oxide Synthase Type II
  • Cyclooxygenase 2
  • Interleukin-1 Receptor-Associated Kinases
  • Irak1 protein, mouse
  • Extracellular Signal-Regulated MAP Kinases
  • JNK Mitogen-Activated Protein Kinases
  • p38 Mitogen-Activated Protein Kinases
  • MAP Kinase Kinase Kinases
  • MAP kinase kinase kinase 7
  • Dinoprostone